The Guardian view on the WHO pandemic treaty: the west’s fantasy negotiations have put the world at risk | Editorial – Image for illustrative purposes only (Image credits: Unsplash)
Negotiations over a long-promised international agreement to strengthen pandemic preparedness have reached an impasse after five years of talks. A coalition of countries from the global south has refused to move forward, insisting that any new framework must address the stark imbalances in vaccine access that defined the Covid-19 response. The standoff underscores how unresolved questions from the last global health emergency continue to shape diplomatic priorities today.
The Uneven Legacy of Covid-19 Vaccine Rollouts
Countries across the global south experienced the pandemic’s health and economic effects in ways that differed sharply from wealthier nations. Vaccines arrived later, in smaller quantities, and often at higher per-dose costs, leaving populations more vulnerable for longer periods. These delays contributed to higher rates of preventable illness and death while also prolonging disruptions to trade, education, and employment.
The experience left many governments convinced that existing international mechanisms had failed to deliver fair outcomes. Officials in affected regions have repeatedly highlighted how early stockpiling by high-income countries limited supply for everyone else, creating a pattern they are determined not to repeat.
Why a New Treaty Was Seen as Essential
Health experts and governments have long argued that clearer rules are needed before the next outbreak emerges. A binding agreement under the World Health Organization could set standards for surveillance, data sharing, and rapid response, reducing the risk that isolated events escalate into worldwide crises. Proponents viewed the treaty as a practical step toward coordinated action rather than a symbolic gesture.
Yet the process has exposed deep divisions over how benefits and burdens should be distributed. Western negotiators, particularly those from European capitals, advanced detailed proposals on preparedness measures while treating questions of equitable access as secondary issues to be resolved later.
The Recent Breakdown in Talks
Last week’s decision by a group of developing nations to withhold support brought the five-year effort to a halt. The move signaled that these countries will no longer accept frameworks that leave vaccine allocation decisions largely in the hands of wealthier states. Without their participation, the treaty cannot achieve the broad legitimacy required for effective implementation.
European backers had presented the draft text as largely complete, expecting technical refinements rather than fundamental renegotiation. The assumption overlooked the political reality that many nations now see vaccine equity as the central test of any future agreement.
What Matters Now
The core disagreement centers on whether future vaccine production and distribution will include enforceable commitments to fair sharing, or whether the status quo of ad-hoc donations and market-driven allocation will persist.
Without progress on this point, the treaty risks becoming another document that exists on paper but offers little protection when tested by events. Governments on both sides of the divide recognize that the next pathogen with pandemic potential will arrive without warning, making the current stalemate more than a procedural delay.
Reaching a workable compromise will require western negotiators to treat equity provisions as integral rather than optional. The alternative is a fragmented system in which countries prioritize their own stockpiles, leaving the global response slower and less effective than it could be. How these talks resume will determine whether the lessons of the last five years translate into concrete safeguards or remain unheeded.